Sun Pharmaceutical Industries Limited announced that its Board of Directors meeting, held on July 31, 2026, has concluded. The meeting commenced at 10:50 A.M., was adjourned for a break, and subsequently resumed to finish at 3:40 P.M. This marks the formal conclusion of the board’s deliberations for this session.
Board Meeting Concludes
Sun Pharmaceutical Industries Limited has officially announced the conclusion of its Board of Directors meeting held on July 31, 2026. The meeting began at 10:50 A.M. and, after a scheduled adjournment for a break, was resumed and subsequently concluded at 3:40 P.M. This communication follows up on an earlier notification dated July 31, 2026, regarding the meeting.
Key Personnel
The announcement was made on behalf of Sun Pharmaceutical Industries Limited by Anoop Deshpande, Company Secretary and Compliance Officer, bearing ICSI Membership No. A23983. His digital signature is affixed to the document, dated July 31, 2026, at 18:13:45 +05’30’.
Source: BSE
